Insider Transactions in Q2 2021 at Emergent Bio Solutions Inc. (EBS)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 25
2021
|
Kathryn C Zoon Director |
SELL
Open market or private sale
|
Direct |
3,139
-17.92%
|
$175,784
$56.48 P/Share
|
|
May 20
2021
|
Jerome M Hauer Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,027
+24.83%
|
-
|
|
May 20
2021
|
Marvin L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,027
+36.74%
|
-
|
|
May 20
2021
|
George A Joulwan Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,027
+13.65%
|
-
|
|
May 20
2021
|
Ronald Richard Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,027
+27.43%
|
-
|
|
May 20
2021
|
Zsolt Harsanyi Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
5,027
+14.52%
|
-
|
|
May 20
2021
|
Kathryn C Zoon Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,027
+22.3%
|
-
|
|
May 20
2021
|
Louis W Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,027
+10.05%
|
-
|
|
May 10
2021
|
Louis W Sullivan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,118
-7.24%
|
$190,198
$61.62 P/Share
|
|
May 10
2021
|
Louis W Sullivan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,305
+19.31%
|
$185,490
$18.64 P/Share
|
|
May 08
2021
|
Robert Kramer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-0.06%
|
$5,734
$61.62 P/Share
|
|
May 08
2021
|
Richard S Lindahl EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,054
-2.78%
|
$64,294
$61.62 P/Share
|
|
May 07
2021
|
Karen L. Smith EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
305
-2.5%
|
$18,300
$60.85 P/Share
|